Reported Reactions

Devices › Prosthesis, breast, noninflatable, internal, silicone gel-filled

Device brand name · Prosthesis breast noninflatable internal silicone gel-filled

Style 410 Cohesive Silicone Gel Filled Breast Implant: medical device reports filed with FDA

15,287 reports name it, 2013–2026. Manufacturer given most often on reports: Allergan Costa Rica. Product code FTR.

15,287
device reports naming the brand
0.1% of all MAUDE reports · about 1,147 a year
1,841
reports, 12 months to August 2026
1,769 in the 12 months before
0.1%
classified as malfunction
1.6% across the product code
0.1%
classified as death, as reported
11 reports · not verified by FDA

15,287 medical device reports received by FDA name the brand "Style 410 Cohesive Silicone Gel Filled Breast Implant" (prosthesis breast noninflatable internal silicone gel-filled); the manufacturer given most often on reports is Allergan Costa Rica; received from March 2013 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

1,841 reports arrived in the 12 months to August 2026, close to the 1,769 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.8%), malfunction (0.1%) and death (0.1%); across all prosthesis, breast, noninflatable, internal, silicone gel-filled reports (product code FTR) death is recorded in 0.1% and malfunction in 1.6%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are material rupture (58.4%), device appears to trigger rejection (28.3%) and patient-device incompatibility (10.3%). The patient problems coded most often are failure of implant, capsular contracture and seroma. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0107214Sep 2021: 91Oct 2021: 91Nov 2021: 174Dec 2021: 1812022Jan 2022: 163Feb 2022: 140Mar 2022: 138Apr 2022: 188May 2022: 176Jun 2022: 214Jul 2022: 205Aug 2022: 189Sep 2022: 152Oct 2022: 187Nov 2022: 205Dec 2022: 2102023Jan 2023: 179Feb 2023: 190Mar 2023: 189Apr 2023: 183May 2023: 117Jun 2023: 152Jul 2023: 148Aug 2023: 156Sep 2023: 95Oct 2023: 141Nov 2023: 179Dec 2023: 1302024Jan 2024: 170Feb 2024: 152Mar 2024: 178Apr 2024: 191May 2024: 159Jun 2024: 140Jul 2024: 146Aug 2024: 158Sep 2024: 117Oct 2024: 169Nov 2024: 164Dec 2024: 1612025Jan 2025: 151Feb 2025: 157Mar 2025: 138Apr 2025: 148May 2025: 125Jun 2025: 160Jul 2025: 162Aug 2025: 117Sep 2025: 147Oct 2025: 160Nov 2025: 146Dec 2025: 1762026Jan 2026: 143Feb 2026: 118Mar 2026: 151Apr 2026: 206May 2026: 163Jun 2026: 167Jul 2026: 153Aug 2026: 111

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01,1752,3502013: 1720132014: 72015: 3620152016: 212017: 7820172018: 1172019: 1,86120192020: 2,3502021: 1,87020212022: 2,1672023: 1,85920232024: 1,9052025: 1,78720252026: 1,212

Event type and report source

Event type, as classified on the report

Death0.1%11
Injury99.8%15,260
Malfunction0.1%16
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%15,287
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 231,877 reports carrying product code FTR. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Material rupture8,92758.4%42.7%
Device appears to trigger rejection4,33028.3%21.6%
Patient-device incompatibilitythe device did not suit the patient1,57010.3%6.6%
Migrationthe device moved from where it was placed4452.9%2.4%
Gel leak1390.9%1.9%
Malposition of device880.6%0.5%
Device handling problem410.3%0.2%
Fluid/blood leak330.2%0.2%
Improper or incorrect procedure or method190.1%0.1%
Insufficient device problem information140.1%0.2%
Device dislodged or dislocated120.1%0%
Material invagination80.1%0%
Migration or expulsion of device70%0.2%
Breakthe device broke60%0.5%
Biofilm coating in device40%0%
Folded30%0%
Material deformation30%0.2%
Biocompatibility20%0%
Defective devicethe device was defective20%0%
Device contamination with chemical or other material20%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant6,89345.1%
Capsular contracturescar tissue tightening around an implant5,88738.5%
Seromaa collection of fluid under the skin2,14614%
Swollen lymph nodes/glands4653%
Lymphomaa cancer of the lymphatic system3782.5%
Granuloma3582.3%
Swollen lymph nodes1591%
Anaplastic large cell lymphoma1240.8%
Breast implant associated anaplastic large cell lymphoma (bia alcl)1170.8%
Painpain, site not specified980.6%
Inflammationinflammation690.5%
Appropriate clinical signs, symptoms and conditions term/code not available680.4%
Breast mass650.4%
Necrosisdeath of tissue530.3%
Wound dehiscencea wound reopened440.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureStyle 410 Cohesive Silicone Gel Filled Breast ImplantProduct code FTRAll MAUDE reports
Reports15,287231,87726,136,888
Share of that pool—6.6%0.1%
Classified as death, per 1,000 reports119
Classified as injury99.8%97.7%36.2%
Classified as malfunction0.1%1.6%62.3%
Filed by the manufacturer100%95%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code FTR

BrandReportsLatest 12 monthsClassified as death
MENTOR MemoryGel Breast Implant57,7717,7080%
Inspira Smooth Silicone Gel Filled Breast Implant35,6346,7820%
Inspira Textured Silicone Gel Filled Breast Implant24,7952,7660%
Style 15 Silicone Gel Filled Breast Implant9,5671,5290.1%
Style 20 Silicone Gel Filled Breast Implant6,3689810.1%
Sientra Silicone Gel Breast Implants6,0141,6820%
Style 115 Silicone Gel Filled Breast Implant5,7105460%
Unknown Gel Implants5,3377030%
UNK Gel Breast Implant5,3027820.4%
MENTOR MemoryGel Xtra Breast Implant4,9101,3870%
Inspira Smooth Cohesive Silicone Gel Filled Breast Implant4,6361,0760%
Sientra Opus Silicone Gel Breast Implant4,61300%
Style 110 Silicone Gel Filled Breast Implant3,3642790%
Style 10 Silicone Gel Filled Breast Implant3,3534790.1%
Style 120 Silicone Gel Filled Breast Implant2,8812120.1%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Style 410 Cohesive Silicone Gel Filled Breast Implant reports

How many FDA reports name Style 410 Cohesive Silicone Gel Filled Breast Implant?

15,287 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,841 in the latest 12 months.

What kinds of events are reported?

injury (99.8%), malfunction (0.1%) and death (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

material rupture (58.4%), device appears to trigger rejection (28.3%), patient-device incompatibility (10.3%), migration (2.9%) and gel leak (0.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Style 410 Cohesive Silicone Gel Filled Breast Implant was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.